FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sten Madsbad

Research Profile

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Theodoros Intzilakis; Preman Kumarathurai; Sten Madsbad; Mette R Mouridsen; Thomas P Almdal; Jesper Eugen-Olsen; Gro Hartmann; Steen B Haugaard; Ahmed Sajadieh
Soluble urokinase plasminogen activator receptor, C-reactive protein and triglyceride are associated with heart rate variability in non-diabetic Danes.
C Dirksen; D L Hansen; Jens Juul Holst; S H Jacobsen; N B Jørgensen; U Kielgast; Sten Madsbad; K N Bojsen-Møller; M Damgaard; L S Naver; D Worm; Jan Lysgård Madsen
Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass.
Jørgen L Jeppesen; Allan Linneberg; Sten Madsbad; Søren J Nielsen; Michael H Olsen; Christian Torp-Pedersen; Nikolaj D Berg; Tine W Hansen; Mogens Fenger
Genetic variation in the natriuretic peptide system, circulating natriuretic peptide levels, and blood pressure: an ambulatory blood pressure study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sten Madsbad (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Theodoros Intzilakis; Preman Kumarathurai; Sten Madsbad; Mette R Mouridsen; Thomas P Almdal; Jesper Eugen-Olsen; Gro Hartmann; Steen B Haugaard; Ahmed Sajadieh
Soluble urokinase plasminogen activator receptor, C-reactive protein and triglyceride are associated with heart rate variability in non-diabetic Danes.
European journal of clinical investigation 2013;43(5):457-68.
2013: C Dirksen; D L Hansen; Jens Juul Holst; S H Jacobsen; N B Jørgensen; U Kielgast; Sten Madsbad; K N Bojsen-Møller; M Damgaard; L S Naver; D Worm; Jan Lysgård Madsen
Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2013;25(4):346-e255.
2012: Jørgen L Jeppesen; Allan Linneberg; Sten Madsbad; Søren J Nielsen; Michael H Olsen; Christian Torp-Pedersen; Nikolaj D Berg; Tine W Hansen; Mogens Fenger
Genetic variation in the natriuretic peptide system, circulating natriuretic peptide levels, and blood pressure: an ambulatory blood pressure study.
American journal of hypertension 2012;25(10):1095-100.
2012: Sten Madsbad; Kjeld Hermansen
[New pharmacological treatment methods of type 2 diabetes].
Ugeskrift for laeger 2012;174(37):2143-6.
2012: Sten Madsbad
[Type 2-diabetes--a coherent health care system needed].
Ugeskrift for laeger 2012;174(37):2131.
2012: Pernille F Svendsen; Lisbeth Nilas; Steen B Haugaard; Jens J Holst; Frank K Jensen; Sten Madsbad
The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women.
Scandinavian journal of clinical and laboratory investigation 2012;72(5):410-9.
2012: Pernille Fog Svendsen; Michael Christiansen; Paula Louise Hedley; Lisbeth Nilas; Steen Bønløkke Pedersen; Sten Madsbad
Adipose expression of adipocytokines in women with polycystic ovary syndrome.
Fertility and sterility 2012;98(1):235-41.
2012: Sten Madsbad
Type 2 diabetes: which drug as add-on to metformin?
Lancet 2012;379(9833):2222-3.
2012: Filip K Knop; Thure Krarup; K Aaboe; J J Holst; Tina Vilsbøll; A Vølund; Sten Madsbad
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Diabetes, obesity & metabolism 2012;14(6):500-10.
2012: D H Jensen; K Aaboe; Jan Erik Henriksen; Jens Juul Holst; Sten Madsbad; Aage Voelund; Thure Krarup
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes.
Diabetologia 2012;55(5):1406-16.
2012: Steen B Haugaard; Ove Andersen; Knut Borch-Johnsen; Jesper Eugen-Olsen; T W Hansen; Torben Jørgensen; Allan Linneberg; Sten Madsbad; M H Olsen; J Jeppesen
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
Diabetic medicine : a journal of the British Diabetic Association 2012;29(4):479-87.
2012: Sten Madsbad
Dipeptidyl peptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) agonists: no.
European journal of internal medicine 2012;23(2):132-6.
2012: Signe Schmidt; Henrik Bengtsson; Anne Katrine Duun-Henriksen; Daniel A Finan; Jens Juul Holst; John Bagterp Jørgensen; Sten Madsbad; Henrik Madsen; Kirsten Nørgaard
Effects of everyday life events on glucose, insulin, and glucagon dynamics in continuous subcutaneous insulin infusion-treated type 1 diabetes: collection of clinical data for glucose modeling.
Diabetes technology & therapeutics 2012;14(3):210-7.
2012: K S Burgdorf; Anette P Gjesing; Niels Grarup; Torben Hansen; Torben Jørgensen; J M Justesen; Sten Madsbad; C H Sandholt; Daniel R Witte; Oluf Pedersen
Association studies of novel obesity-related gene variants with quantitative metabolic phenotypes in a population-based sample of 6,039 Danish individuals.
Diabetologia 2012;55(1):105-13.
2011: Signe S Torekov; J Wang; Daniel R Witte; M Rosenkilde; Annelli Sandbaek; Niels Grarup; I A Hainerová; Torben Hansen; Bolette Hartmann; Jens Juul Holst; Torben Jørgensen; U Kielgast; Hannelouise Kissow; torsten lauritzen; J Lebl; A Linneberg; L Ma; Sten Madsbad; O D Madsen; Oluf Pedersen
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1.
Diabetologia 2011;54(11):2820-31.
2011: Rasmus Rabøl; Peter Schjerling; Mette Skovbro; Pernille F Svendsen; Robert Boushel; Sten Madsbad; Lisbeth Nilas; Flemming Dela
Skeletal muscle mitochondrial function in polycystic ovarian syndrome.
European journal of endocrinology / European Federation of Endocrine Societies 2011;165(4):631-7.
2011: Sten Madsbad
[Treatment of diabetes during hospitalization--still a challenge].
Ugeskrift for laeger 2011;173(39):2399.
2011: Urd Kielgast; Thure Krarup; Jens Juul Holst; Sten Madsbad
Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.
Diabetes care 2011;34(7):1463-8.
2011: S K Holfort; E Hommel; G R Jackson; Kristian Klemp; Sten Madsbad; Inger Christine Munch; K Nørgaard; Birgit Sander; Michael Larsen
Retinal function in relation to improved glycaemic control in type 1 diabetes.
Diabetologia 2011;54(7):1853-61.
2011: S Larsen; N Stride; M Hey-Mogensen; C N Hansen; J L Andersen; Sten Madsbad; D Worm; Jørn Wulff Helge; Flemming Dela
Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetes.
Diabetologia 2011;54(6):1427-36.
2011: Jens J Holst; Filip K Knop; Tina Vilsbøll; Thure Krarup; Sten Madsbad
Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes.
Diabetes care 2011;34 Suppl 2():S251-7.
2011: Urd Kielgast; Jens J Holst; Sten Madsbad
Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
Diabetes 2011;60(5):1599-607.
2011: Sten Madsbad; Signe S Torekov; M Asmar; C F Deacon; U Kielgast; Jens Juul Holst
An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.
Diabetes, obesity & metabolism 2011;13(5):394-407.
2011: Sten Madsbad
[Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review].
Ugeskrift for laeger 2011;173(8):564-7.
2011: Mogens Fenger; Jesper Eugen-Olsen; Torben Jørgensen; Allan Linneberg; Sten Madsbad; Karen Søbye; Jørgen Jeppesen
Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension.
BMC genetics 2011;12():44.
2011: Kristoffer Sølvsten Burgdorf; Niels Grarup; Johanne Marie Justesen; Marie Neergaard Harder; Daniel R Witte; Torben Jørgensen; Annelli Sandbaek; torsten lauritzen; Sten Madsbad; Torben Hansen; Oluf Pedersen
Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans.
PloS one 2011;6(1):e15813.
2010: Filip K Knop; Tina Vilsbøll; Steen Larsen; Sten Madsbad; Jens Juul Holst; Thure Krarup
Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis.
Regulatory peptides 2010;164(2-3):144-50.
2010: Rasmus Rabøl; Robert Boushel; Thomas Almdal; C N Hansen; T Ploug; Steen B Haugaard; Clara Prats; Sten Madsbad; Flemming Dela
Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes.
Diabetes, obesity & metabolism 2010;12(9):806-14.
2010: Meena Asmar; Lene Simonsen; Sten Madsbad; Bente Stallknecht; Jens Juul Holst; Jens Bülow
Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans.
Diabetes 2010;59(9):2160-3.
2010: Mikkel Christensen; Filip K Knop; Tina Vilsbøll; Kasper Aaboe; Jens J Holst; Sten Madsbad; Thure Krarup
Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes.
Regulatory peptides 2010;163(1-3):96-101.
2010: Jørgen Jeppesen; Tine W Hansen; Christian Torp-Pedersen; Sten Madsbad; Hans Ibsen; Torben Jørgensen; Mogens Fenger
Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study.
Atherosclerosis 2010;211(2):506-11.
2010: Thomas S G Sehested; Tine W Hansen; Michael H Olsen; Steen Z Abildstrøm; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen; Sten Madsbad; Jørgen Jeppesen
Measures of overweight and obesity and risk of cardiovascular disease: a population-based study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2010;17(4):486-90.
2010: Pernille Fog Svendsen; Sten Madsbad; Lisbeth Nilas
The insulin-resistant phenotype of polycystic ovary syndrome.
Fertility and sterility 2010;94(3):1052-8.
2010: Kristoffer Sølvsten Burgdorf; Camilla Helene Sandholt; Thomas Sparsø; Gitte Andersen; Daniel R Witte; Torben Jørgensen; Anelli Sandbaek; torsten lauritzen; Thorkild I A Sørensen; Sten Madsbad; Torben Hansen; Oluf Pedersen
Studies of association between LPIN1 variants and common metabolic phenotypes among 17,538 Danes.
European journal of endocrinology / European Federation of Endocrine Societies 2010;163(1):81-7.
2010: Urd Kielgast; Meena Asmar; Sten Madsbad; Jens J Holst
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients.
The Journal of clinical endocrinology and metabolism 2010;95(5):2492-6.
2010: Meena Asmar; Michael Bache; Filip Knop; Sten Madsbad; Jens J Holst
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?
The Journal of clinical endocrinology and metabolism 2010;95(5):2367-75.
2010: K Aaboe; Filip K Knop; Tina Vilsbøll; Carolyn F Deacon; Jens Juul Holst; Sten Madsbad; Thure Krarup
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
Diabetes, obesity & metabolism 2010;12(4):323-33.
2010: Steen B Haugaard; Sten Madsbad; H Mu; A Vaag
Desaturation of excess intramyocellular triacylglycerol in obesity: implications for glycemic control.
International journal of obesity (2005) 2010;34(3):500-10.
2010: Meena Asmar; Winnie Tangaa; Sten Madsbad; Kristine Hare; Arne Astrup; Anne Flint; Jens Bülow; Jens Juul Holst
On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans.
American journal of physiology. Endocrinology and metabolism 2010;298(3):E614-21.
2010: Meena Asmar; Patricia V Højberg; Carolyn F Deacon; Kristine Hare; Jens J Holst; Sten Madsbad
Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.
Regulatory peptides 2010;160(1-3):175-80.
2010: Rasmus Rabøl; S Larsen; P M V Højberg; Thomas Almdal; Robert Boushel; Steen B Haugaard; J L Andersen; Sten Madsbad; Flemming Dela
Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity.
The Journal of clinical endocrinology and metabolism 2010;95(2):857-63.
2010: Ove Andersen; Birgitte Rønde Hansen; William Troensegaard; Allan Flyvbjerg; Sten Madsbad; Hans Ørskov; Jens Ole Nielsen; Johan Iversen; Steen B Haugaard
Sustained low-dose growth hormone therapy optimizes bioactive insulin-like growth factor-I level and may enhance CD4 T-cell number in HIV infection.
Journal of medical virology 2010;82(2):197-205.
2010: Carsten Dirksen; Dorte L Hansen; Sten Madsbad; Lisbeth E Hvolris; Lars S Naver; Jens J Holst; Dorte Worm
Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report.
Diabetes care 2010;33(2):375-7.
2009: Kristine J Hare; Filip K Knop; Meena Asmar; Sten Madsbad; Carolyn F Deacon; Jens J Holst; Tina Vilsbøll
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus.
The Journal of clinical endocrinology and metabolism 2009;94(12):4679-87.
2009: Urd Kielgast; Jens J Holst; Sten Madsbad
Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists.
Current diabetes reviews 2009;5(4):266-75.
2009: Michael A Nauck; Tina Vilsbøll; Baptist Gallwitz; Alan Garber; Sten Madsbad
Incretin-based therapies: viewpoints on the way to consensus.
Diabetes care 2009;32 Suppl 2():S223-31.
2009: P F Svendsen; Sten Madsbad; Lisbeth Nilas; S K Paulsen; S B Pedersen
Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
International journal of obesity (2005) 2009;33(11):1249-56.
2009: Anne-Louise Hother Nielsen; Thomas Meinert Larsen; Sten Madsbad; Leif Breum; Thomas Jon Jensen; Jens Peter Kroustrup; Arne Astrup
[The effect of tesofensine on body weight and body composition in obese subjects--secondary publication].
Ugeskrift for laeger 2009;171(41):2974-7.
2009: Sten Madsbad
Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results.
Best practice & research. Clinical endocrinology & metabolism 2009;23(4):463-77.
2009: Rasmus Rabøl; Pernille F Svendsen; Mette Skovbro; Robert Boushel; Steen B Haugaard; Peter Schjerling; Patrick Schrauwen; Matthijs K C Hesselink; Lisbeth Nilas; Sten Madsbad; Flemming Dela
Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss.
Metabolism: clinical and experimental 2009;58(8):1145-52.
2009: Steen B Haugaard; Huiling Mu; Allan Vaag; Sten Madsbad
Intramyocellular triglyceride content in man, influence of sex, obesity and glycaemic control.
European journal of endocrinology / European Federation of Endocrine Societies 2009;161(1):57-64.
2009: Thomas Sparsø; Niels Grarup; C Andreasen; Anders Albrechtsen; J Holmkvist; Gitte Andersen; Torben Jørgensen; Knut Borch-Johnsen; Annelli Sandbaek; Torsten Lauritzen; Sten Madsbad; Torben Hansen; Oluf Pedersen
Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction.
Diabetologia 2009;52(7):1308-14.
2009: K Pilgaard; C B Jensen; J H Schou; V Lyssenko; Lise Wegner; Charlotte Brøns; T Vilsbøll; Torben Hansen; Sten Madsbad; J J Holst; A Vølund; Pernille Poulsen; Leif Groop; Oluf Pedersen; Allan Vaag
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
Diabetologia 2009;52(7):1298-307.
2009: Thomas Sparsø; Amélie Bonnefond; Ehm Andersson; Nabila Bouatia-Naji; Johan Holmkvist; Lise Wegner; Niels Grarup; Anette P Gjesing; Karina Banasik; Christine Cavalcanti-Proença; Marion Marchand; Martine Vaxillaire; Guillaume Charpentier; Marjo-Riitta Jarvelin; Jean Tichet; Beverley Balkau; Michel Marre; Claire Lévy-Marchal; Kristine Faerch; Knut Borch-Johnsen; Torben Jørgensen; Sten Madsbad; Pernille Poulsen; Allan Vaag; Christian Dina; Torben Hansen; Oluf Pedersen; philippe froguel
G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.
Diabetes 2009;58(6):1450-6.
2009: Pernille Fog Svendsen; Lisbeth Nilas; Sten Madsbad; Jens Juul Holst
Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Metabolism: clinical and experimental 2009;58(5):586-93.
2009: Rasmus Rabøl; P M V Højberg; T Almdal; Robert Boushel; Steen B Haugaard; Sten Madsbad; Flemming Dela
Improved glycaemic control decreases inner mitochondrial membrane leak in type 2 diabetes.
Diabetes, obesity & metabolism 2009;11(4):355-60.
2009: Rasmus Rabøl; Patricia M V Højberg; Thomas Almdal; Robert Boushel; Steen B Haugaard; Sten Madsbad; Flemming Dela
Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2009;94(4):1372-8.
2009: Stine Chabert Olesen; Dorte Lindqvist Hansen; Thomas Almdal; Flemming Bendtsen; Inge Nordgaard; Lisbeth Edvardsen Hvolris; Jens J Holst; Lars Naver; Sten Madsbad
[Surgical treatment of diabetes mellitus type 2].
Ugeskrift for laeger 2009;171(8):615-7.
2009: Sten Madsbad
Treatment of type 2 diabetes with incretin-based therapies.
Lancet 2009;373(9662):438-9.
2009: Kasper Aaboe; Filip K Knop; Tina Vilsboll; Aage Voelund; Simonsen Ulf; Carolyn F Deacon; Sten Madsbad; Jens Juul Holst; Thure Krarup
KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2009;94(2):603-8.
2009: P V Højberg; T Vilsbøll; R Rabøl; Filip Knop; M Bache; T Krarup; Jens Juul Holst; Sten Madsbad
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
Diabetologia 2009;52(2):199-207.
2009: Steen B Haugaard; Allan Vaag; Huiling Mu; Sten Madsbad
Skeletal muscle structural lipids improve during weight-maintenance after a very low calorie dietary intervention.
Lipids in health and disease 2009;8():34.
2008: Arne Astrup; Sten Madsbad; Leif Breum; Thomas J Jensen; Jens Peter Kroustrup; Thomas Meinert Larsen
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.
Lancet 2008;372(9653):1906-13.
2008: Sten Madsbad
[Glycemic control and cardiovascular diseases in type 2 diabetes].
Ugeskrift for laeger 2008;170(45):3634.
2008: P V Højberg; T Vilsbøll; Mette Zander; Filip Knop; T Krarup; Aage Voelund; Jens Juul Holst; Sten Madsbad
Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2008;25(11):1268-75.
2008: Kasper Aaboe; Thure Krarup; Sten Madsbad; Jens Juul Holst
GLP-1: physiological effects and potential therapeutic applications.
Diabetes, obesity & metabolism 2008;10(11):994-1003.
2008: Jørgen Jeppesen; Tine W Hansen; Michael H Olsen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen; Per R Hildebrandt; Sten Madsbad
C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2008;15(5):594-8.
2008: Thomas Sparsø; Gitte Andersen; Anders Albrechtsen; Torben Jørgensen; Knut Borch-Johnsen; Annelli Sandbaek; Torsten Lauritzen; J Wasson; M A Permutt; B Glaser; Sten Madsbad; Oluf Pedersen; Torben Hansen
Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation.
Diabetologia 2008;51(9):1646-52.
2008: Pernille Fog Svendsen; Lisbeth Nilas; Kirsten Nørgaard; Jens-Erik Beck Jensen; Sten Madsbad
Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
Human reproduction (Oxford, England) 2008;23(9):2113-21.
2008: Sten Madsbad; Thure Krarup; Carolyn F Deacon; Jens J Holst
Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials.
Current opinion in clinical nutrition and metabolic care 2008;11(4):491-9.
2008: Lone Skov; Laszlo Hegedüs; Sten Madsbad; Klaus Bendtzen
[New biological drugs for the treatment of chronic inflammatory diseases].
Ugeskrift for laeger 2008;170(24):2162.
2008: Jens J Holst; Carolyn F Deacon; Tina Vilsbøll; Thure Krarup; Sten Madsbad
Glucagon-like peptide-1, glucose homeostasis and diabetes.
Trends in molecular medicine 2008;14(4):161-8.
2008: P V Højberg; Mette Zander; T Vilsbøll; Filip Knop; T Krarup; Aage Voelund; Jens Juul Holst; Sten Madsbad
Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.
Diabetologia 2008;51(4):632-40.
2008: Tina Vilsbøll; B Brock; H Perrild; K Levin; H-H Lervang; Klaus Kølendorf; Thure Krarup; O Schmitz; M Zdravkovic; T Le-Thi; Sten Madsbad
Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2008;25(2):152-6.
2008: Christine B Jensen; Malgorzata S Martin-Gronert; Heidi Storgaard; Sten Madsbad; Allan Vaag; Susan E Ozanne
Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight.
PloS one 2008;3(11):e3738.
2008: Thomas Sparsø; Gitte Andersen; T Nielsen; K S Burgdorf; A P Gjesing; A L Nielsen; Anders Albrechtsen; Signe S Rasmussen; Torben Jørgensen; Knut Borch-Johnsen; Annelli Sandbaek; Torsten Lauritzen; Sten Madsbad; Torben Hansen; Oluf Pedersen
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.
Diabetologia 2008;51(1):70-5.
2007: Filip K Knop; Tina Vilsbøll; Patricia V Højberg; Steen Larsen; Sten Madsbad; Jens J Holst; Thure Krarup
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
Regulatory peptides 2007;144(1-3):123-30.
2007: Sten Madsbad
[Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review].
Ugeskrift for laeger 2007;169(47):4054-7.
2007: Thomas Sparsø; Meena Shaheen Hussain; Knut Borch-Johnsen; Torben Jørgensen; Sten Madsbad; Torben Hansen; Oluf Pedersen; Gitte Andersen
Studies of association of the CASQ1 rs2275703 polymorphism in relation to type 2 diabetes and related quantitative metabolic traits among 7,088 Danish whites.
Molecular genetics and metabolism 2007;92(3):278-82.
2007: Ove Andersen; Steen Pedersen; Birgit Svenstrup; Birgitte R Hansen; Søren K Paulsen; Gulla S Rathje; Bjørn Richelsen; Jens Ole Nielsen; Sten Madsbad; Johan Iversen; Steen B Haugaard
Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution.
Clinical endocrinology 2007;67(2):250-8.
2007: Filip K Knop; Tina Vilsbøll; Patricia V Højberg; Steen Larsen; Sten Madsbad; Aage Voelund; Jens J Holst; Thure Krarup
Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?
Diabetes 2007;56(8):1951-9.
2007: Steen B Haugaard; Ove Andersen; Ian Halsall; Johan Iversen; C Nicholas Hales; Sten Madsbad
Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution.
Metabolism: clinical and experimental 2007;56(7):939-46.
2007: Tina Vilsbøll; Milan Zdravkovic; Tu Le-Thi; Thure Krarup; Ole Schmitz; Jean-Pierre Courrèges; Robert Verhoeven; Ingrid Bugánová; Sten Madsbad
Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.
Diabetes care 2007;30(6):1608-10.
2007: Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen; Sten Madsbad
Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
Journal of the American College of Cardiology 2007;49(21):2112-9.
2007: Christine B Jensen; Heidi Storgaard; Sten Madsbad; Erik A Richter; Allan Vaag
Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weight.
The Journal of clinical endocrinology and metabolism 2007;92(4):1530-4.
2007: Filip K Knop; Tina Vilsbøll; Sten Madsbad; Jens Juul Holst; Thure Krarup
Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.
Diabetologia 2007;50(4):797-805.
2007: Steen B Haugaard; Allan Vaag; Carl-Erik Høy; Sten Madsbad
Desaturation of skeletal muscle structural and depot lipids in obese individuals during a very-low-calorie diet intervention.
Obesity (Silver Spring, Md.) 2007;15(1):117-25.
2007: Bjørn Richelsen; Serena Tonstad; Stephan Rössner; Søren Toubro; Leo Niskanen; Sten Madsbad; Pertti Mustajoki; Aila Rissanen
Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
Diabetes care 2007;30(1):27-32.
2007: Filip K Knop; Tina Vilsbøll; Steen Larsen; Patricia V Højberg; Aage Voelund; Sten Madsbad; Jens J Holst; Thure Krarup
Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.
American journal of physiology. Endocrinology and metabolism 2007;292(1):E324-30.
2007: Steen B Haugaard; Ove Andersen; Sten Madsbad; Johan Iversen; Flemming Dela
Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART.
The Journal of infection 2007;54(1):89-97.
2006: Tina Vilsbøll; Henrik Agersø; Torsten Lauritsen; Carolyn F Deacon; Kasper Aaboe; Sten Madsbad; Thure Krarup; Jens Juul Holst
The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.
Regulatory peptides 2006;137(3):168-72.
2006: Jakob Ryskjaer; Carolyn F Deacon; Richard D Carr; Thure Krarup; Sten Madsbad; Jens Holst; Tina Vilsbøll
Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(3):485-93.
2006: Steen B Haugaard; Ove Andersen; C Nicholas Hales; Ian Halsall; A M Rosenfalck; Johan Iversen; Sten Madsbad
Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients.
European journal of clinical investigation 2006;36(6):436-45.
2006: Steen B Haugaard; Ove Andersen; Allan Flyvbjerg; Hans Ørskov; Sten Madsbad; Johan Iversen
Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophy.
The Journal of infection 2006;52(6):389-98.
2006: Ole E Schmitz; Birgitte Brock; Jørgen Rungby; Sten Madsbad
[The place of Glitazones in the treatment of diabetes: after the PROactive study].
Ugeskrift for laeger 2006;168(18):1750-2.
2006: Sten Madsbad; Mogens Lytken Larsen; Haagen F Adeler; Marianne Kryhlmand; Mogens Westergaard
[Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes].
Ugeskrift for laeger 2006;168(17):1640-5.
2006: AM Rosenfalck; T Almdal; L Viggers; Sten Madsbad; Jannik Hilsted
A low-fat diet improves peripheral insulin sensitivity in patients with Type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(4):384-92.
2006: Steen B Haugaard; Ove Andersen; Steen Pedersen; Flemming Dela; C F Deacon; Jens Juul Holst; Johan Iversen; Sten Madsbad
Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy.
HIV medicine 2006;7(3):163-72.
2006: Karim Bouzakri; Håkan Karlsson; Henrik Vestergaard; Sten Madsbad; Erik Christiansen; Juleen R Zierath
IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients.
Diabetes 2006;55(3):785-91.
2006: Steen B Haugaard; Sten Madsbad; Carl-Erik Høy; Allan Vaag
Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity.
Clinical endocrinology 2006;64(2):169-78.
2006: Steen B Haugaard; Ove Andersen; Steen Pedersen; Flemming Dela; Mogens Fenger; Bjørn Richelsen; Sten Madsbad; Johan Iversen
Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
Metabolism: clinical and experimental 2006;55(2):175-82.
2006: Mette Zander; Sten Madsbad; C F Deacon; Jens Juul Holst
The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.
Diabetologia 2006;49(2):369-74.
2006: Sten Madsbad; Bjørn Richelsen
[Weight loss treatment of obese type 2 diabetic patients].
Ugeskrift for laeger 2006;168(2):175-9.
2006: Tina Berentzen; Sten Madsbad; Thorkild I A Sørensen; Arne V Astrup
[The importance of physical activity and fitness in avoiding the complications of obesity].
Ugeskrift for laeger 2006;168(2):144-9.
2005: Steen B Haugaard; Ove Andersen; Sten Madsbad; Christian Frøsig; Johan Iversen; Jens Ole Nielsen; Jørgen F P Wojtaszewski
Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy.
Diabetes 2005;54(12):3474-83.
2005: Emma Carlsson; Pernille Poulsen; Heidi Storgaard; Peter Almgren; Charlotte Ling; Christine B Jensen; Sten Madsbad; Leif Groop; Allan Vaag; Martin Ridderstråle
Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle.
Diabetes 2005;54(10):3015-20.
2005: Christine B Jensen; Heidi Storgaard; Jens Juul Holst; Flemming Dela; Sten Madsbad; Allan Vaag
Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controls.
Metabolism: clinical and experimental 2005;54(10):1398-406.
2005: G He; Ove Andersen; Steen B Haugaard; Aina S Lihn; Steen Pedersen; Sten Madsbad; Bjørn Richelsen
Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
European journal of clinical investigation 2005;35(9):583-90.
2005: C Bing; Louise Ambye; Mogens Fenger; T Jørgensen; Knut Borch-Johnsen; Sten Madsbad; Søren A Urhammer
Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(9):1157-60.
2005: Steen B Haugaard; Ove Andersen; Steen Pedersen; Flemming Dela; Bjørn Richelsen; Jens Ole Nielsen; Sten Madsbad; Johan Iversen
Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Journal of medical virology 2005;77(1):29-38.
2005: Pernille Fog Svendsen; Lisbeth Nilas; Kirsten Nørgaard; Sten Madsbad
[Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Ugeskrift for laeger 2005;167(34):3147-51.
2005: Jakob Hagen Schou; Kasper Pilgaard; Tina Vilsbøll; Christine B Jensen; Carolyn F Deacon; Jens Juul Holst; Aage Voelund; Sten Madsbad; Allan Vaag
Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
The Journal of clinical endocrinology and metabolism 2005;90(8):4912-9.
2005: Ove Andersen; Steen B Haugaard; Jens Juul Holst; C F Deacon; Johan Iversen; Ulrik B Andersen; Jens Ole Nielsen; Sten Madsbad
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
HIV medicine 2005;6(2):91-8.
2005: Steen B Haugaard; Ove Andersen; Aage Voelund; Birgitte R Hansen; Johan Iversen; Ulrik B Andersen; Jens Ole Nielsen; Sten Madsbad
Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
Clinical endocrinology 2005;62(3):354-61.
2005: Susan E Ozanne; Christine B Jensen; KJ Tingey; Heidi Storgaard; Sten Madsbad; Allan Vaag
Low birthweight is associated with specific changes in muscle insulin-signalling protein expression.
Diabetologia 2005;48(3):547-52.
2005: Steen B Haugaard; Ove Andersen; Birgitte R Hansen; Ulrik B Andersen; Aage Voelund; Johan Iversen; Jens Ole Nielsen; Sten Madsbad
In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
Metabolism: clinical and experimental 2005;54(2):171-9.
2005: Louise Ambye; Susanne Rasmussen; Mogens Fenger; Torben Jørgensen; Knut Borch-Johnsen; Sten Madsbad; Søren A Urhammer
Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
Diabetes research and clinical practice 2005;67(2):175-9.
2005: Steen B Haugaard; Ove Andersen; Flemming Dela; Jens Juul Holst; Heidi Storgaard; Mogens Fenger; Johan Iversen; Sten Madsbad
Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(1):103-12.
2005: Eva Lind Rasmussen; Charlotte Malis; Christine B Jensen; Jens-Erik Beck Jensen; Heidi Storgaard; Pernille Poulsen; Kasper Pilgaard; Jacob Hagen Schou; Sten Madsbad; Arne Astrup; Allan Vaag
Altered fat tissue distribution in young adult men who had low birth weight.
Diabetes care 2005;28(1):151-3.
2004: Steen B Haugaard; Ove Andersen; Birgitte R Hansen; Hans Orskov; Ulrik B Andersen; Sten Madsbad; Johan Iversen; Allan Flyvbjerg
Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients.
Metabolism: clinical and experimental 2004;53(12):1565-73.
2004: Anthony H Barnett; Stephen C Bain; Paul Bouter; Bengt Karlberg; Sten Madsbad; Jak Jervell; Jukka Mustonen
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
The New England journal of medicine 2004;351(19):1952-61.
2004: Steen B Haugaard; Ove Andersen; Heidi Storgaard; Flemming Dela; Jens Juul Holst; Johan Iversen; Jens Ole Nielsen; Sten Madsbad
Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.
American journal of physiology. Endocrinology and metabolism 2004;287(4):E677-85.
2004: Ove Andersen; Steen B Haugaard; Allan Flyvbjerg; Ulrik B Andersen; Hans Ørskov; Sten Madsbad; Jens Ole Nielsen; Johan Iversen
Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study.
European journal of clinical investigation 2004;34(8):561-8.
2004: Mette Zander; Allan Christiansen; Sten Madsbad; Jens Juul Holst
Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.
Diabetes care 2004;27(8):1910-4.
2004: Sten Madsbad; Ole Schmitz; Jonas Ranstam; Grethe Jakobsen; David R Matthews
Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.
Diabetes care 2004;27(6):1335-42.
2004: Sten Madsbad; Arne V Astrup
[Obesity, the metabolic syndrome and cardiovascular disease].
Ugeskrift for laeger 2004;166(17):1561-4.
2004: Heidi Storgaard; Christine B Jensen; Marie Björnholm; Xiao Mei Song; Sten Madsbad; Juleen R Zierath; Allan Vaag
Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2004;89(3):1301-11.
2004: Ove Andersen; Steen B Haugaard; Birgitte R Hansen; Hans Orskov; Ulrik B Andersen; Sten Madsbad; Johan Iversen; Allan Flyvbjerg
Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.
Scandinavian journal of infectious diseases 2004;36(11-12):832-9.
2003: Aina S Lihn; Bjørn Richelsen; Steen Pedersen; Steen B Haugaard; Gulla Søby Rathje; Sten Madsbad; Ove Andersen
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
American journal of physiology. Endocrinology and metabolism 2003;285(5):E1072-80.
2003: Birgitte R Hansen; Steen B Haugaard; Jens Ole Nielsen; Sten Madsbad; Johan Iversen; Ove Andersen
[Control and treatment of HIV-associated lipodystrophy syndrome and related metabolic complications].
Ugeskrift for laeger 2003;165(44):4218-20.
2003: Steen B Haugaard; Birgitte R Hansen; Sten Madsbad; Johan Iversen; Jens Ole Nielsen; Ove Andersen
[HIV-associated lipodystrophy syndrome. Diagnosis, prevalence, pathogenesis and metabolic complications].
Ugeskrift for laeger 2003;165(44):4215-8.
2003: Ove Andersen; Steen B Haugaard; Ulrik B Andersen; Nina Friis-Møller; Heidi Storgaard; Aage Voelund; Jens Ole Nielsen; Johan Iversen; Sten Madsbad
Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function.
Metabolism: clinical and experimental 2003;52(10):1343-53.
2003: Tina Vilsbøll; Filip K Knop; Thure Krarup; A Johansen; Sten Madsbad; Steen Larsen; T Hansen; O Pedersen; Jens Juul Holst
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
The Journal of clinical endocrinology and metabolism 2003;88(10):4897-903.
2003: Filip K Knop; Tina Vilsbøll; Steen Larsen; Sten Madsbad; Jens J Holst; Thure Krarup
No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis.
Diabetes care 2003;26(9):2581-7.
2003: Sten Madsbad; Birgitte Brock; Ole Schmitz
[Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
Ugeskrift for laeger 2003;165(33):3149-53.
2003: Tina Vilsbøll; Thure Krarup; Sten Madsbad; Jens J Holst
Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Regulatory peptides 2003;114(2-3):115-21.
2003: Heidi Storgaard; Christine B Jensen; Allan Vaag; Aage Voelund; Sten Madsbad
Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes.
Metabolism: clinical and experimental 2003;52(7):885-94.
2003: Christine B Jensen; Heidi Storgaard; Jens J Holst; Flemming Dela; Sten Madsbad; Allan Vaag
Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men.
The Journal of clinical endocrinology and metabolism 2003;88(6):2775-83.
2003: Tina Vilsbøll; Thure Krarup; J Sonne; Sten Madsbad; Aage Voelund; A G Juul; Jens Juul Holst
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
The Journal of clinical endocrinology and metabolism 2003;88(6):2706-13.
2003: L Frederiksen; K Brødbaek; Mogens Fenger; Sten Madsbad; Søren A Urhammer; T Jørgensen; K Borch-Johnsen
No interactions between polymorphisms in the beta3-adrenergic receptor gene and the PPAR-gamma gene on the risk of the insulin resistance syndrome in the Danish MONICA cohort.
Diabetologia 2003;46(5):729-31.
2003: Lise L Kjems; Jens J Holst; Aage Voelund; Sten Madsbad
The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.
Diabetes 2003;52(2):380-6.
2003: Ove Andersen; Steen B Haugaard; L T Jørgensen; Susanne Sørensen; Jens Ole Nielsen; Sten Madsbad; Johan Iversen
Preanalytical handling of samples for measurement of plasma lactate in HIV patients.
Scandinavian journal of clinical and laboratory investigation 2003;63(6):449-54.
2002: Kerstin Andersson; Karsten Buschard; Pam Fredman; Anne Kaas; Anna-Maria Lidström; Sten Madsbad; Henrik Mortensen; Månsson Jan-Eric
Patients with insulin-dependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assay.
Autoimmunity 2002;35(7):463-8.
2002: Tina Vilsbøll; Thure Krarup; Sten Madsbad; Jens Juul Holst
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Diabetologia 2002;45(8):1111-9.
2002: Laura Frederiksen; Kasper Brødbaek; Mogens Fenger; Torben Jørgensen; Knut Borch-Johnsen; Sten Madsbad; Søren A Urhammer
Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome.
The Journal of clinical endocrinology and metabolism 2002;87(8):3989-92.
2002: Karsten Buschard; Marianne Høy; Krister Bokvist; Hervør L Olsen; Sten Madsbad; Pam Fredman; Jesper Gromada
Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells.
Diabetes 2002;51(8):2514-21.
2002: Kjeld Hermansen; Stein Vaaler; Sten Madsbad; Marian Dalgaard; Mette Zander; Kamilla Begtrup; Karsten Soendergaard
Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes.
Metabolism: clinical and experimental 2002;51(7):896-900.
2002: AM Rosenfalck; T Almdal; Jannik Hilsted; Sten Madsbad
Body composition in adults with Type 1 diabetes at onset and during the first year of insulin therapy.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(5):417-23.
2002: Kjeld Hermansen; Michele Colombo; Heidi Storgaard; Anette ØStergaard; Klaus Kølendorf; Sten Madsbad
Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.
Diabetes care 2002;25(5):883-8.
2002: Allan Lindskov Christiansen; Sten Madsbad
[Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
Ugeskrift for laeger 2002;164(15):2025-8.
2002: Allan Lindskov Christiansen; Sten Madsbad
[The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
Ugeskrift for laeger 2002;164(15):2022-4.
2002: Christine B Jensen; Heidi Storgaard; Flemming Dela; Jens Juul Holst; Sten Madsbad; Allan Vaag
Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight.
Diabetes 2002;51(4):1271-80.
2002: Mette Zander; Sten Madsbad; Jan Lysgård Madsen; Jens Juul Holst
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
Lancet 2002;359(9309):824-30.
2002: Sten Madsbad
Insulin analogues: have they changed insulin treatment and improved glycaemic control?
Diabetes/metabolism research and reviews 2002;18 Suppl 1():S21-8.
2002: AM Rosenfalck; Helle W Hendel; Michael Rasmussen; T Almdal; T Anderson; Jannik Hilsted; Sten Madsbad
Minor long-term changes in weight have beneficial effects on insulin sensitivity and beta-cell function in obese subjects.
Diabetes, obesity & metabolism 2002;4(1):19-28.
2001: Heidi Storgaard; X M Song; Christine B Jensen; Sten Madsbad; Marie Björnholm; Allan Vaag; Juleen R Zierath
Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Diabetes 2001;50(12):2770-8.
2001: Ole E Schmitz; Birgitte Brock; Sten Madsbad; Henning Beck-Nielsen
[Thiazolidinediones--a new class of oral antidiabetics].
Ugeskrift for laeger 2001;163(44):6106-11.
2001: Lise L Kjems; Aage Voelund; Sten Madsbad
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.
Diabetologia 2001;44(10):1339-48.
2001: MB Toft-Nielsen; Sten Madsbad; Jens Juul Holst
Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2001;86(8):3853-60.
2001: MB Toft-Nielsen; M B Damholt; Sten Madsbad; LM Hilsted; Thomas Hughes; B K Michelsen; Jens Juul Holst
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
The Journal of clinical endocrinology and metabolism 2001;86(8):3717-23.
2001: Sten Madsbad; B Kilhovd; I Lager; P Mustajoki; A Dejgaard
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
Diabetic medicine : a journal of the British Diabetic Association 2001;18(5):395-401.
2001: Mette Zander; M Taskiran; MB Toft-Nielsen; Sten Madsbad; Jens Juul Holst
Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.
Diabetes care 2001;24(4):720-5.
2001: Tina Vilsbøll; Thure Krarup; Carolyn F Deacon; Sten Madsbad; Jens Juul Holst
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
Diabetes 2001;50(3):609-13.
2001: Tina Vilsbøll; Thure Krarup; Sten Madsbad; Jens Juul Holst
No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose.
Diabetic medicine : a journal of the British Diabetic Association 2001;18(2):144-9.
2001: Kjeld Hermansen; Sten Madsbad; H Perrild; A Kristensen; M Axelsen
Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.
Diabetes care 2001;24(2):296-301.
2001: Allan Lindskov Christiansen; Sten Madsbad
[Jet leg].
Ugeskrift for laeger 2001;163(2):149-55.
2000: AM Rosenfalck; S Maghsoudi; Sanne Fisker; Jens Otto Lunde Jørgensen; Jens Sandahl Christiansen; Jannik Hilsted; A A Vølund; Sten Madsbad
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
The Journal of clinical endocrinology and metabolism 2000;85(11):4173-81.
2000: Jens Otto Lunde Jørgensen; AM Rosenfalck; Sanne Fisker; Birgit Nyholm; Mark S Fineman; Ole Schmitz; Sten Madsbad; J J Holst; Jens Sandahl Christiansen
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(5):593-9.
2000: Tina Vilsbøll; MB Toft-Nielsen; Thure Krarup; Sten Madsbad; B Dinesen; Jens Juul Holst
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
Diabetes care 2000;23(6):807-12.
2000: Lise L Kjems; E Christiansen; Aage Voelund; R N Bergman; Sten Madsbad
Validation of methods for measurement of insulin secretion in humans in vivo.
Diabetes 2000;49(4):580-8.
2000: AM Rosenfalck; Per Medbøe Thorsby; L Kjems; Kåre I Birkeland; A Dejgaard; Kristian F Hanssen; Sten Madsbad
Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
Acta diabetologica 2000;37(1):41-6.
1999: JJ Larsen; Flemming Dela; Sten Madsbad; Henrik Galbo
The effect of intense exercise on postprandial glucose homeostasis in type II diabetic patients.
Diabetologia 1999;42(11):1282-92.
1999: JJ Larsen; Flemming Dela; Sten Madsbad; J Vibe-Petersen; Henrik Galbo
Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients.
Diabetes care 1999;22(10):1647-54.
1999: MB Toft-Nielsen; Sten Madsbad; Jens Juul Holst
Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
Diabetes care 1999;22(7):1137-43.
1999: AM Rosenfalck; Sanne Fisker; Jannik Hilsted; B Dinesen; A Vølund; Jens Otto Lunde Jørgensen; Jens Sandahl Christiansen; Sten Madsbad
The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9(2):96-105.
1998: MB Toft-Nielsen; Sten Madsbad; Jens Juul Holst
Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
Diabetologia 1998;41(10):1180-6.
1998: E Christiansen; ME Røder; A Tibell; C N Hales; Sten Madsbad
Effect of pancreas transplantation and immunosuppression on proinsulin secretion.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(9):739-46.
1998: E Christiansen; Lise L Kjems; Aage Voelund; A Tibell; C Binder; Sten Madsbad
Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients.
The American journal of physiology 1998;274(4 Pt 1):E716-25.
1997: E Christiansen; A Tibell; Aage Voelund; J J Holst; K Rasmussen; L Schäffer; Sten Madsbad
Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance.
The Journal of clinical endocrinology and metabolism 1997;82(7):2299-307.
1996: E Christiansen; A Tibell; A Vølund; Knud Rasmussen; C G Groth; Jens Juul Holst; Oluf Pedersen; Niels Juel Christensen; Sten Madsbad
Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation.
The Journal of clinical endocrinology and metabolism 1996;81(11):3972-9.
1996: Jannik Hilsted; Sten Madsbad; Michael Rasmussen; A Hvidberg; T Krarup; Henrik Ipsen; B Hansen; M Pedersen; R Djurup; B Oxenbøll
[Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus].
Ugeskrift for laeger 1996;158(24):3451-5.
1996: M Toft-Nielson; Sten Madsbad; Jens Juul Holst
The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.
Diabetes 1996;45(5):552-6.
1996: H A Frandsen; Soren Snitker; Niels Juel Christensen; Sten Madsbad
No differential effects of porcine and human insulin on muscle sympathetic nerve activity during euglycaemia or hypoglycaemia.
Clinical physiology (Oxford, England) 1996;16(1):9-21.
1996: K Bech; P Damsbo; E Eldrup; Henning Beck-Nielsen; ME Røder; S G Hartling; A Vølund; Sten Madsbad
beta-cell function and glucose and lipid oxidation in Graves' disease.
Clinical endocrinology 1996;44(1):59-66.
1995: Jannik Hilsted; Sten Madsbad; A Hvidberg; Michael Rasmussen; T Krarup; Henrik Ipsen; B Hansen; M Pedersen; R Djurup; B Oxenbøll
Intranasal insulin therapy: the clinical realities.
Diabetologia 1995;38(6):680-4.
1995: H B Andersen; E Christiansen; A Vølund; Sten Madsbad; K Rasmussen; Flemming Burcharth; Niels Juel Christensen
Sham feeding increases glucose tolerance by a mechanism independent of insulin secretion in normal subjects.
Digestion 1995;56(3):253-8.
1994: Sten Madsbad; E Christiansen; A Tibell; G Tydén; K Rasmussen; F Burcharth
Beta-cell dysfunction following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation.
Transplantation proceedings 1994;26(2):469-70.
1994: E Christiansen; A Tibell; C G Groth; K Rasmussen; Oluf Pedersen; Flemming Burcharth; Niels Juel Christensen; A Vølund; Sten Madsbad
Limitations in the use of insulin or C-peptide alone in the assessment of beta-cell function in pancreas transplant recipients. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation.
Transplantation proceedings 1994;26(2):467-8.
1993: Jens Juul Holst; M Bersani; A Hvidberg; U Knigge; E Christiansen; Sten Madsbad; H Harling; Hans Kofod
On the effects of human galanin in man.
Diabetologia 1993;36(7):653-7.
1993: E Christiansen; A Tibell; K Rasmussen; G Tydén; Sten Madsbad
Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation (DSSGMEPT).
Transplantation proceedings 1993;25(1 Pt 2):1186-9.
1992: H B Andersen; E W Jensen; Sten Madsbad; S L Nielsen; Flemming Burcharth; Niels Juel Christensen
Sham-feeding decreases cardiac output in normal subjects.
Clinical physiology (Oxford, England) 1992;12(4):439-42.
1992: B Grønlund; L Grønlund; Sten Madsbad; N Fogh-Andersen
Clinical evaluation of a prototype glucose electrode.
Biosensors & bioelectronics 1992;7(10):683-7.
1991: L Saelsen; B Tronier; Sten Madsbad; Niels Juel Christensen
A rapid method for determination of human C-peptide in plasma.
Clinica chimica acta; international journal of clinical chemistry 1991;196(1):1-6.
1991: B Grønlund; H Frandsen; M Lauritzen; S L Nielsen; Sten Madsbad
Effect of insulin-induced hypoglycaemia on absorption of unmodified insulin after subcutaneous or intramuscular injection.
Diabetic medicine : a journal of the British Diabetic Association 1991;8(1):13-7.